Literature DB >> 7788995

I-123 MIBG imaging of metastatic carcinoid tumor from the rectum.

N Watanabe1, H Seto, M Ishiki, M Shimizu, M Kageyama, Y W Wu, T Nagayoshi, Y Kamisaki, M Kakishita.   

Abstract

I-131 MIBG, a specific radiopharmaceutical agent for scintigraphic imaging and treatment of pheochromocytoma and neuroblastoma may be useful for detection of apudomas. Scintigraphy with I-123 radiolabeled MIBG was performed in a patient with metastatic carcinoid tumor from the rectum. I-123 MIBG scintigraphic findings showed multiple areas of abnormal tumor uptake of hepatic and bone metastases from the rectal carcinoid. Bone scintigraphy demonstrated multiple metastatic lesions. Computed tomography revealed multiple solid tumors of the liver. This report describes accumulation of I-123 MIBG in the liver and bone metastases from the rectal carcinoid. Radioiodine MIBG scintigraphy may be useful for detecting metastatic lesions, for evaluating postoperative recurrence, and also for the treatment of the carcinoid tumor.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7788995     DOI: 10.1097/00003072-199504000-00014

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  2 in total

1.  Carcinoid tumours.

Authors:  J S Davies; J Green; C Currie
Journal:  Postgrad Med J       Date:  1997-12       Impact factor: 2.401

2.  Management of sub-5 mm rectal carcinoids with lymph node metastases.

Authors:  James Wei Tatt Toh; Christopher Henderson; Takako Eva Yabe; Evonne Ong; Pierre Chapuis; Les Bokey
Journal:  Gastroenterol Rep (Oxf)       Date:  2014-10-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.